Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Rodden M Middleton"'
Autor:
Kerina H Jones, Philip A Jones, Rodden M Middleton, David V Ford, Katie Tuite-Dalton, Hazel Lockhart-Jones, Jeffrey Peng, Ronan A Lyons, Ann John, J Gareth Noble
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e104604 (2014)
INTRODUCTION:People with Multiple Sclerosis are known to have a relatively high prevalence of both anxiety and depression. Studies of the relationship between physical disability and mental health in people with MS have reported mixed results, showin
Externí odkaz:
https://doaj.org/article/ef227fc560f840d5a3b529516ca3cbd9
Autor:
Kerina H Jones, David V Ford, Philip A Jones, Ann John, Rodden M Middleton, Hazel Lockhart-Jones, Jeffrey Peng, Lisa A Osborne, J Gareth Noble
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e65640 (2013)
The EQ-5D is a widely-used, standardised, quality of life measure producing health profiles, indices and states. The aims of this study were to assess the role of various factors in how people with Multiple Sclerosis rate their quality of life, based
Externí odkaz:
https://doaj.org/article/da103ccfbaa548ab8ff73d628ab93285
Autor:
Kerina H Jones, David V Ford, Philip A Jones, Ann John, Rodden M Middleton, Hazel Lockhart-Jones, Jeffrey Peng, Lisa A Osborne, J Gareth Noble
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e55422 (2013)
The MSIS-29 was developed to assess the physical and psychological impact of MS. The aims of this study were to use the responses to the MSIS-29 via the web portal of the UK MS Register to: examine the internal properties of the scale delivered via t
Externí odkaz:
https://doaj.org/article/ec173b6242f14864954d8e43fe055243
Autor:
Kerina H Jones, David V Ford, Philip A Jones, Ann John, Rodden M Middleton, Hazel Lockhart-Jones, Lisa A Osborne, J Gareth Noble
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41910 (2012)
Studies have found that people with Multiple Sclerosis experience relatively high rates of anxiety and depression. Although methodologically robust, many of these studies had access to only modest sample sizes (N4000) to: describe the depression and
Externí odkaz:
https://doaj.org/article/10908d7e8fcd49489010f87fab258193
Autor:
Georgina Arrambide, Ingrid van der Mei, Raed Alroughani, Lars Forsberg, Rodden M. Middleton, Guilherme Sciascia do Olival, Nikola Lazovski, Rumen Ivanov, Alexander Stahmann, Tomas Kalincik, Helmut Butzkueven, Richard S. Nicholas, J. Hillert, Alice Estavo Dias, Edward De Brouwer, Amber Salter, Serkan Ozakbas, Nupur Nag, Doralina Guimarães Brum, Alexander Fidao, Anna Zabalza, Yves Moreau, Ricardo Alonso, Anneke Van Der Walt, Nick Rijke, Lotte Geys, Anibal Chertcoff, Arnfin Bergmann, Robert N. McBurney, Clare Walton, Anna Glaser, Tina Parciak, Gilles Edan, Clément Gautrais, Ashkan Pirmani, Maria Fernanda Mendes, Juan Ignacio Rojas, Melinda Magyari, Liesbet M. Peeters, Robert J. Fox, Hollie Schmidt, Amin Ardeshirdavanai, Steve Simpson-Yap, Stefan Braune, Giancarlo Comi, Johana Bauer, Tim Spelman
Publikováno v:
Scientia
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Neurology
article-version (Version of Record) 3
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Neurology
article-version (Version of Record) 3
Made available in DSpace on 2022-04-28T19:46:29Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-11-09 Background and ObjectivesPeople with multiple sclerosis MS are a vulnerable group for severe coronavirus disease 2019 COVID-19, particularly
Autor:
Niklas Frahm, Firas Fneish, David Ellenberger, Judith Haas, Micha Loebermann, Tina Parciak, Melanie Peters, Dieter Pöhlau, Jeff Rodgers, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Uwe K. Zettl, Rodden M. Middleton
Background Vaccines offer people with multiple sclerosis (PwMS) an effective protection against severe COVID-19 disease courses. However, representative real-world data on the tolerability of SARS-CoV-2 vaccines in PwMS are limited. We aimed at analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e201399582501d764a5efa4f4114408
https://cronfa.swan.ac.uk/Record/cronfa61480/Download/61480__25537__20b8a19244f949519d68fadcb6099a74.pdf
https://cronfa.swan.ac.uk/Record/cronfa61480/Download/61480__25537__20b8a19244f949519d68fadcb6099a74.pdf
Background and ObjectivesTo understand the course of recovery from coronavirus disease 2019 (COVID-19) among patients with multiple sclerosis (MS) and to determine its predictors, including patients' pre–COVID-19 physical and mental health status.M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5033c451be88231e8e04f0428478f3ee
https://cronfa.swan.ac.uk/Record/cronfa59132/Download/59132__22097__b6423119082342529266004d4b7e6a59.pdf
https://cronfa.swan.ac.uk/Record/cronfa59132/Download/59132__22097__b6423119082342529266004d4b7e6a59.pdf
Autor:
Lotte Geyes, Nikola Lazovski, Ingrid van der Mei, Ricardo Alonso, Anna Glaser, Tomas Kalincik, Tina Parciak, Rumen Ivanov, Richard Nicholas, Arnfin Bergmann, Gilles Edan, Ashkan Pirmani, Hollie Schmidt, Amber Salter, Robert J. Fox, Steve Simpson-Yap, Johana Bauer, Jan Hillert, Liesbet Peeters, Giancarlo Comi, Amin Ardeshirdavani, Helmut Butzkueven, Alexander Fidao, Anibal Chertcoff, Alice Estavo Dias, Robert N. McBurney, Melinda Magyari, Lars Forsberg, Ana Zabalza, Georgina Arrambide, Alexander Stahmann, Rodden M. Middleton, Nupur Nag, Doralina Guimarães Brum, Nick Rijke, Guilherme Sciascia do Olival, Tim Spelman, Juan Ignacio Rojas, Edward De Brouwer, Clare Walton, Anneke van der Walt, Clément Gautrais, Maria Fernandes Mendes, Stefan Braune
Publikováno v:
International Journal of Epidemiology. 50
Background People with multiple sclerosis (MS) are a vulnerable group for severe COVID-19, particularly those taking immunosuppressive disease-modifying therapies (DMTs). We examined the characteristics of COVID-19 severity in an international sample
Autor:
Maura Pugliatti, Kerstin Hellwig, Jaume Sastre-Garriga, Jens Kuhle, Jan Hillert, Peter Flachenecker, Giampaolo Brichetto, Otto Rienhoff, Konstantinos Notas, P. Seeldrayers, K. Lycke, Susana Otero-Romero, Anna Glaser, Merja Soilu-Hänninen, Kjell-Morten Myhr, A.C. de Giacomoni, Tjalf Ziemssen, Tatjana Pekmezovic, Paola Zaratin, Helmut Butzkueven, Maria Trojano, Mario Alberto Battaglia, Kerstin Eichstädt, Romain Casey, Melinda Magyari, Pietro Iaffaldano, Alexander Stahmann, Sandra Vukusic, Waldemar Brola, Christoph Thalheim, Jelena Drulovic, T. Meissner, E. Ioannidou, Rodden M. Middleton, T. Malbaša, Leszek Stawiarz, Dana Horakova, Anastasios Orologas
Publikováno v:
Glaser, A, Stahmann, A, Meissner, T, Flachenecker, P, Horáková, D, Zaratin, P, Brichetto, G, Pugliatti, M, Rienhoff, O, Vukusic, S, de Giacomoni, A C, Battaglia, M A, Brola, W, Butzkueven, H, Casey, R, Drulovic, J, Eichstädt, K, Hellwig, K, Iaffaldano, P, Ioannidou, E, Kuhle, J, Lycke, K, Magyari, M, Malbaša, T, Middleton, R, Myhr, K M, Notas, K, Orologas, A, Otero-Romero, S, Pekmezovic, T, Sastre-Garriga, J, Seeldrayers, P, Soilu-Hänninen, M, Stawiarz, L, Trojano, M, Ziemssen, T, Hillert, J & Thalheim, C 2019, ' Multiple sclerosis registries in Europe – An updated mapping survey ', Multiple Sclerosis and Related Disorders, vol. 27, pp. 171-178 . https://doi.org/10.1016/j.msard.2018.09.032
ObjectivesTo assess the prevalence of long COVID among people with multiple sclerosis (MS) and its predictors, including their pre-COVID-19 functional status.DesignCommunity-based prospective and longitudinal cohort studySettingThe United Kingdom (UK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f40877b15a3819db98d833797a1278f8
https://doi.org/10.1101/2021.06.25.21259256
https://doi.org/10.1101/2021.06.25.21259256